State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, PR China; YMU-HKBU Joint Laboratory of Traditional Natural Medicine, Yunnan Minzu University, Kunming 650500, PR China.
School of Traditional Chinese Pharmacy and State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, PR China; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, PR China.
J Ethnopharmacol. 2018 Jun 28;220:220-227. doi: 10.1016/j.jep.2017.10.026. Epub 2017 Oct 31.
Rubia yunnanensis is a medicinal plant mainly grown in Yunnan province in Southwest China, and its root named "Xiaohongshen" has been used as a herb in Yunnan for the treatment of cancers. Three major types of chemical components, Rubiaceae-type cyclopeptides, quinones, and triterpenoids, were identified from R. yunnanensis, in which some of compounds including rubiarbonol G (RG), a unique arboriane-type triterpenoid, showed cytotoxicity on cancer cells. But the cytotoxic mechanism of RG has not been reported.
To investigate the cytotoxic mechanism of RG on cancer cells.
RG was evaluated its cytotoxicity on 7 cancer cell lines by the SRB assay, and detected the effect on apoptosis and cell cycle arrest by Annexin V-FITC/PI apoptosis assay and DNA contents analysis. The expression and activity of apoptosis and cell cycle related proteins were also investigated by western blot and caspase activity assay. Furthermore, the effect of RG on NF-κB signaling was also tested by luciferase assay, western blot, and immunofluorescence staining.
RG showed potent cytotoxicity on 7 human cancer cell lines, whose activity was attributed to apoptosis induction and G/G arrest in HeLa cells. Results from the mechanism study showed that RG promoted the activation of ERK1/2 and JNK pathway in MAPK family, which in turn increased the expression of p53, thereby triggering the G/G arrest through p53/p21/cyclin D1 signaling. Moreover, RG-mediated JNK activation down-regulated the expression of the anti-apoptotic protein Bcl-2, which caused the release of cytochrome c to the cytosol and activated the cleavage of caspase cascade and poly(ADP-ribose) polymerase, thereby inducing apoptosis in HeLa cells. In addition, RG was also found to inhibit the activation of NF-κB signaling by down-regulating the expression and attenuating the translocation to nucleus of NF-κB p65, by which the down-stream p53, cyclin D1, Bcl-2, and caspases were regulated, thereby triggering apoptosis and G/G arrest in HeLa cells.
These results indicated that RG induces mitochondria-mediated apoptosis and G/G cell cycle arrest by activation of JNK signaling as well as inactivation of NF-κB pathway in HeLa cells, which suggests that RG is one of the key active ingredients accounting for the anti-tumor effect of R. yunnanensis.
云南小茜草是一种主要生长在中国西南部云南省的药用植物,其根部名为“小红参”,在云南被用作治疗癌症的草药。从小茜草中分离出了三种主要类型的化学成 分:茜草科环肽、醌类和三萜类,其中包括化合物 rubiarbonol G (RG),一种独特的 arboriane 型三萜,对癌细胞具有细胞毒性。但是,RG 的细胞毒性机制尚未报道。
探讨 RG 对癌细胞的细胞毒性机制。
通过 SRB 测定法评估 RG 对 7 种癌细胞系的细胞毒性,并通过 Annexin V-FITC/PI 凋亡测定法和 DNA 含量分析检测其对细胞凋亡和细胞周期阻滞的影响。还通过 Western blot 和半胱天冬酶活性测定法研究了凋亡和细胞周期相关蛋白的表达和活性。此外,通过荧光素酶测定法、Western blot 和免疫荧光染色法还测试了 RG 对 NF-κB 信号通路的影响。
RG 对 7 个人类癌细胞系表现出强大的细胞毒性,其活性归因于 HeLa 细胞中诱导的细胞凋亡和 G1/G0 期阻滞。机制研究结果表明,RG 促进了 MAPK 家族中 ERK1/2 和 JNK 途径的激活,进而增加了 p53 的表达,从而通过 p53/p21/cyclin D1 信号通路触发 G1/G0 期阻滞。此外,RG 介导的 JNK 激活下调了抗凋亡蛋白 Bcl-2 的表达,导致细胞色素 c 释放到细胞质中,并激活 caspase 级联和多聚(ADP-核糖)聚合酶的切割,从而诱导 HeLa 细胞凋亡。此外,还发现 RG 通过下调 NF-κB p65 的表达并减弱其向核内易位来抑制 NF-κB 信号通路的激活,从而调节下游的 p53、cyclin D1、Bcl-2 和半胱天冬酶,从而触发 HeLa 细胞中的凋亡和 G1/G0 期阻滞。
这些结果表明,RG 通过激活 JNK 信号通路以及抑制 NF-κB 通路的失活,诱导 HeLa 细胞中线粒体介导的凋亡和 G1/G0 期细胞周期阻滞,提示 RG 是云南小茜草发挥抗肿瘤作用的关键活性成分之一。